Pharma Partnering Flashcards
What is partnering in the pharmaceutical industry?
A collaboration between two or more companies to discover, develop, or commercialize a medicine, aiming to share value and leverage complementary strengths.
What are the different stages at which pharma partnering can occur?
Research (early-stage),
Development (clinical trials),
Geographic (new regions),
Commercial (co-promotion/marketing),
Licensing,
Joint Ventures.
What core functions can pharma companies partner to support?
Research, Development, Manufacturing, Regulatory Affairs, Commercial Strategy, Country-specific Presence.
List key types of pharmaceutical companies involved in partnering.
Early-Stage Incubators, Big Pharma, Specialist Biopharma, Generics, Commercialization-Based, Partner/Distributors, CMOs, VC/PE-backed, Public Companies.
Why do pharma companies choose to partner?
To fill capability gaps, access markets, share financial risk, speed up development, and increase commercial potential.
What are key components of a partnering deal?
Deal term, upfront payments, royalties, equity/shares, performance milestones, decision-making rights, geographic splits, licensing rights, exit clauses.
What factors are assessed to value a pharma asset before partnering?
Market potential, clinical trial data, regulatory outlook, and competition; evaluated through base, upside, and downside case models.
What are common partnering models in pharma?
Co-Promotion, Co-Marketing, Co-Development, Licensing Out, Manufacturing Partnerships, M&A.
Give an example of a co-marketing pharma partnership.
Lisinopril was co-marketed by Zeneca (Zestril) and Merck (Prinivil).
What are the main risks in pharma partnerships?
Financial risks (overpayment), operational issues (culture, legal), competitive risks (confidentiality, overlap), and unequal contributions.
How can risks in partnering be mitigated?
Clearly define responsibilities, create firewalls, formalize decision-making and dispute mechanisms.
What are the key steps in establishing a pharma partnership?
Identify partners → Initial meetings → Due diligence → NDA → Negotiate terms → Finalize deal.
Where do major pharma partnering deals often occur?
JP Morgan Healthcare Conference – key networking and negotiation venue for pharma deals.
What is crucial for managing a pharma partnership successfully?
Set expectations, assign financial duties, regular reviews, and conflict resolution mechanisms.
What are common challenges in managing pharma partnerships?
Legal/regulatory differences, cultural clashes, M&A disruptions.
What are alternative pharma partnering models?
University collaborations, Public-Private Partnerships (PPPs), Data-driven partnerships, Charity-backed R&D partnerships.
What are key takeaways about partnering in pharma?
It accelerates development, shares risk/reward, requires careful structuring, and relies on strong alliance management.
